Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06504290 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Evaluating Safety, Tolerability and Pharmacokinetic of Multiple Ascending Doses of VV119

StatusRecruiting
PhasePhase 1
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated August 14, 2026 (before its estimated October 1, 2026 completion). Its status may not reflect the trial's current state.
Trial flagged as At Risk
Primary completion moved at least 3 months later Jul 1, 2026 → Oct 1, 2026
See other at-risk trials from Vigonvita Life Sciences

Record History

  1. Primary and study completion pushed from Jul 1, 2026 to Oct 1, 2026v9
  2. Primary and study completion pushed from Apr 1, 2026 to Jul 1, 2026v8
  3. Primary and study completion dates: Dec 1, 2025 to Apr 1, 2026v7
  4. Enrollment target: 32 to 40v6
  5. Primary and study completion dates: Jul 1, 2025 to Dec 1, 2025v5
Show 3 earlier versionsHide 3 earlier versions
  1. Study sites: 3 to 4v4
  2. Re-verified, no change to tracked fieldsv3
  3. Trial status: Not Yet Recruiting to Recruiting Study sites: 0 to 3 · Start date changed from estimate of Jul 10, 2024 to Jul 16, 2024v2 Show 2 more changesShow less
    • Study sites: 0 to 3
    • Start date changed from estimate of Jul 10, 2024 to Jul 16, 2024
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study will consist of 2 parts: Part Ⅰ-in healthy adult subjects, Part Ⅱ-in adult patients with schizophrenia
Trial Details
NCT Number NCT06504290
Lead Sponsor Vigonvita Life Sciences
Conditions Schizophrenia
Enrollment 40 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov